These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6686634)

  • 1. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine.
    Ramabadran K
    Life Sci; 1983; 33 Suppl 1():385-8. PubMed ID: 6686634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of precipitated withdrawal in rats acutely dependent on morphine.
    Ramabadran K
    Jpn J Pharmacol; 1985 Apr; 37(4):307-16. PubMed ID: 2989597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)].
    Tremblay E; Colombel MC; Jacob J
    Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.
    Menon MK; Tseng LF; Loh HH; Clark WG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):43-9. PubMed ID: 7190227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.
    Linseman MA
    Psychopharmacology (Berl); 1977 Oct; 54(2):159-64. PubMed ID: 412210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intraventricular infusion model for inducing morphine dependence in rats: quantitative assessment of precipitated withdrawal.
    Huffman RD; Simmons KE; Lum JT
    Behav Neurosci; 1985 Oct; 99(5):861-80. PubMed ID: 3843305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats.
    Sayin U; Atasoy S; Uzbay IT; Aricioğlu-Kartal F; Koyuncuoğlu H
    Pharmacol Res; 1998 Jul; 38(1):45-51. PubMed ID: 9697154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
    de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
    Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats.
    Gomaa A; Hashem T; Mohamed M; Ashry E
    J Pharmacol Sci; 2003 May; 92(1):50-5. PubMed ID: 12832855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats.
    Chen JC; Tao PL; Li JY; Wong CH; Huang EY
    Peptides; 2003 Mar; 24(3):477-81. PubMed ID: 12732348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.